Archives
Cannabis use During Pregnancy and Postpartum
18 Feb, 2020 | 08:12h | UTCCannabis use during pregnancy and postpartum – Canadian Family Physician (free)
Related: AAP Clinical Report: Implications of Marijuana Use During Pregnancy and Breastfeeding (free report and commentaries)
“There is no known safe level of cannabis use during pregnancy or lactation”
[Abstract Only] Randomized Trial: Adverse Effects of Low-Dose Methotrexate
18 Feb, 2020 | 08:08h | UTCAdverse Effects of Low-Dose Methotrexate: A Randomized Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: Study investigates rates of adverse events for common rheumatoid arthritis drug – Brigham and Women’s Hospital (free) AND Low-dose methotrexate use ‘has inherent risks’ – Medicine Matters (free)
A Clinician’s Guide to Artificial Intelligence: How to Critically Appraise Machine Learning Studies
18 Feb, 2020 | 08:07h | UTC
Related Commentary on Twitter
What an outstanding guide to critique medical #AI studies.
Just missing the link: https://t.co/re6JGh30rM#openaccess @ARVOtvst
From the leading 👀AI team!
and a pretty good editor @pearsekeane 😉 https://t.co/lFcIeGOAKo pic.twitter.com/vAx5VySHxB— Eric Topol (@EricTopol) February 17, 2020
Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with BCL-2 Inhibitors: Risk Factors, Prophylaxis, and Treatment Recommendations
18 Feb, 2020 | 08:04h | UTCTumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations – The Lancet Haematology (free registration required)
Management of Dermatologic Adverse Events from Cancer Therapies
18 Feb, 2020 | 08:05h | UTC
Meta-Analysis: Incidental Brain MRI Findings in Children
18 Feb, 2020 | 08:04h | UTCIncidental Brain MRI Findings in Children: A Systematic Review and Meta-Analysis – American Journal of Neuroradiology (free)
Meta-Analysis: Subglottic Secretion Drainage for Preventing Ventilator-associated Pneumonia
18 Feb, 2020 | 08:01h | UTC
Opinion Article – Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue
18 Feb, 2020 | 08:03h | UTCRelated: Perspective: Use of ‘Smart Drugs’ on the Rise (several texts on the subject)
Current and Future Applications of Liquid Biopsy in Nonsmall Cell Lung Cancer from Early to Advanced Stages
18 Feb, 2020 | 08:02h | UTC
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU
16 Feb, 2020 | 21:42h | UTCNews Release: New guidelines for hepatic failure in the intensive care unit – Wolters Kluwer Health (free)
See also: Executive Summary (free)
Mon February 17 – 10 Stories of The Day!
16 Feb, 2020 | 21:46h | UTC
News Release: New guidelines for hepatic failure in the intensive care unit – Wolters Kluwer Health (free)
See also: Executive Summary (free)
See also: Mitral Regurgitation Management Focused Update: Key Points – American College of Cardiology (free)
3 – A Randomized Controlled Trial of Ceftriaxone and Doxycycline, with or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease – Clinical Infectious Diseases (link to abstract – $ for full-text)
News Release: Chronic kidney disease a ‘global killer in plain sight’ – Institute for Health Metrics and Evaluation (free)
Commentaries: The global burden of chronic kidney disease – The Lancet (free) AND Chronic kidney disease killing millions worldwide – News Medical (free) AND Chronic kidney disease kills more than 1M people annually worldwide – UPI (free)
5 – 65 Trial – The Bottom Line (free) AND The 65 trial: Is 60 the new 65? – PulmCrit (free)
Original Study: Randomized Trial: Comparison of Different Blood Pressure Targets for Vasopressor Therapy in Older Critically Ill Patients with Vasodilatory Hypotension – JAMA (free)
6 – Alex Nowbar’s weekly journal review, 14 February 2020 – The BMJ Opinion (free)
“Alex Nowbar reviews the latest research from the top medical journals.”
Source: Lorcaserin (Belviq ) Withdrawn From US Market Due to Cancer Risk – Medscape (free registration required)
Related: FDA Safety Communication: Possible Increased Risk of Cancer with Weight-loss Medicine Lorcaserin (free)
8 – Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis – The American Journal of Gastroenterology (link to abstract – $ for full-text)
Commentary: Fecal Occult Blood Tests Should Not Be Used for Diagnostic Indications – NEJM Journal Watch (free for a limited period)
9 – An electroencephalographic signature predicts antidepressant response in major depression – Nature Biotechnology (link to abstract – $ for full-text)
Commentaries: Neural signature identifies people likely to respond to antidepressant medication – NIH News Releases (free) AND Brain-wave pattern can identify people likely to respond to antidepressant, study finds – Stanford Medicine (free) AND AI, brain scans may alter how doctors treat depression – UT Southwestern Medical Center (free) AND Brain scans could be used to identify who will benefit from antidepressants – Business Insider (free) AND Resting-State EEG Can Predict Sertraline Treatment Outcomes – MPR (free) AND Will That Antidepressant Work For You? The Answer May Lie In Your Brain Waves – NPR (free)
10 – Novel Coronavirus Disease (COVID-19) Latest Articles, Guidelines, News & Perspectives / 17 February 2020 Edition
17 February 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)
[Abstract Only] Randomized Trial: Ceftriaxone and Doxycycline, with or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease
16 Feb, 2020 | 21:39h | UTCA Randomized Controlled Trial of Ceftriaxone and Doxycycline, with or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease – Clinical Infectious Diseases (link to abstract – $ for full-text)
Related Commentary on Twitter
NEW ⚡🔥#CID
Randomized Controlled Trial of Ceftriaxone and Doxycycline, with or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease. #IDTwitter @PittHealthSci @PittsburghPG https://t.co/L4IWzRJRhi pic.twitter.com/GJeJxqxOq4— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) February 13, 2020
2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation
16 Feb, 2020 | 21:41h | UTCSee also: Mitral Regurgitation Management Focused Update: Key Points – American College of Cardiology (free)
Global, Regional, and National Burden of Chronic Kidney Disease
16 Feb, 2020 | 21:38h | UTCNews Release: Chronic kidney disease a ‘global killer in plain sight’ – Institute for Health Metrics and Evaluation (free)
Commentaries: The global burden of chronic kidney disease – The Lancet (free) AND Chronic kidney disease killing millions worldwide – News Medical (free) AND Chronic kidney disease kills more than 1M people annually worldwide – UPI (free)
Related Commentary on Twitter
NEW #GBDStudy provides latest data for global, regional, and national burden of chronic kidney disease, 1990–2017. In 2017, 1·2 million people died from chronic #kidneydisease, with global all-age mortality rate rising 41.5% between 1990 and 2017 @IHME_UW https://t.co/pxWenSGBfJ pic.twitter.com/nT0VQltWsj
— The Lancet (@TheLancet) February 14, 2020
Alex Nowbar’s weekly journal review—14 February 2020
16 Feb, 2020 | 21:34h | UTCAlex Nowbar’s weekly journal review, 14 February 2020 – The BMJ Opinion (free)
“Alex Nowbar reviews the latest research from the top medical journals.”
FDA Requests the Withdrawal of the Weight-loss Drug Lorcaserin from the Market – Potential Risk of Cancer Outweighs the Benefits
16 Feb, 2020 | 21:33h | UTCSource: Lorcaserin (Belviq ) Withdrawn From US Market Due to Cancer Risk – Medscape (free registration required)
Related: FDA Safety Communication: Possible Increased Risk of Cancer with Weight-loss Medicine Lorcaserin (free)
Study Commentaries: The 65 Trial – Comparison of Different Blood Pressure Targets for Vasopressor Therapy
16 Feb, 2020 | 21:36h | UTC65 Trial – The Bottom Line (free) AND The 65 trial: Is 60 the new 65? – PulmCrit (free)
Original Study: Randomized Trial: Comparison of Different Blood Pressure Targets for Vasopressor Therapy in Older Critically Ill Patients with Vasodilatory Hypotension – JAMA (free)
Consensus Statement: Management of Traumatic Meniscus Tears
16 Feb, 2020 | 21:10h | UTC
ASCO Guideline: Management of Male Breast Cancer
16 Feb, 2020 | 21:11h | UTCManagement of Male Breast Cancer: ASCO Guideline – Journal of Clinical Oncology (free)
[Abstract Only] Study: An Electroencephalographic Signature Predicts Antidepressant Response in Major Depression
16 Feb, 2020 | 21:27h | UTCAn electroencephalographic signature predicts antidepressant response in major depression – Nature Biotechnology (link to abstract – $ for full-text)
Commentaries: Neural signature identifies people likely to respond to antidepressant medication – NIH News Releases (free) AND Brain-wave pattern can identify people likely to respond to antidepressant, study finds – Stanford Medicine (free) AND AI, brain scans may alter how doctors treat depression – UT Southwestern Medical Center (free) AND Brain scans could be used to identify who will benefit from antidepressants – Business Insider (free) AND Resting-State EEG Can Predict Sertraline Treatment Outcomes – MPR (free) AND Will That Antidepressant Work For You? The Answer May Lie In Your Brain Waves – NPR (free)
Guidelines for Early Mobilization in the Intensive Care Unit
16 Feb, 2020 | 21:06h | UTC
[Abstract Only] Meta-Analysis: Fecal Occult Blood Testing Should Not be Used as a Diagnostic Tool for Clinical Indications
16 Feb, 2020 | 21:31h | UTCUse of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis – The American Journal of Gastroenterology (link to abstract – $ for full-text)
Commentary: Fecal Occult Blood Tests Should Not Be Used for Diagnostic Indications – NEJM Journal Watch (free for a limited period)
Position Statement: Role of Gastrointestinal Endoscopy in the Screening of Digestive Tract Cancers
16 Feb, 2020 | 21:07h | UTC
Bloodstream Infections in Critically Ill Patients: An Expert Statement
16 Feb, 2020 | 21:03h | UTCBloodstream infections in critically ill patients: an expert statement – Intensive Care Medicine (free)
Meta-Analysis: Determining the Optimal Time for Liberation from Renal Replacement Therapy in Critically Ill Patients
16 Feb, 2020 | 21:19h | UTC